Volume 15; Issue 6

Journal of Medical Economics

Volume 15; Issue 6

1

Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States

Lee, Soyon, Baxter, Daniel C., Limone, Brendan, Roberts, Matthew S., Coleman, Craig I.

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 382 KB

english, 2012

2

Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing–remitting multiple sclerosis in The Netherlands

Heisen, M., Treur, M. J., van der Hel, W. S., Frequin, S. T. F. M., Groot, M. T., Verheggen, B. G.

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 645 KB

english, 2012

3

Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO study

Roggeri, Daniela Paola, Mazzaferro, Sandro, Brancaccio, Diego, Cannella, Giuseppe, Messa, Piergiorgio, Di Luca, Marina, Morosetti, Massimo, Costanzo, Anna Maria, Paparatti, Umberto di Luzio, Cornago,

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 161 KB

english, 2012

4

Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity

Erder, M. Haim, Signorovitch, James E., Setyawan, Juliana, Yang, Hongbo, Parikh, Kejal, Betts, Keith A., Xie, Jipan, Hodgkins, Paul, Wu, Eric Q.

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 372 KB

english, 2012

5

Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis

Iqbal, I., Dasgupta, B., Taylor, P., Heron, L., Pilling, C.

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 220 KB

english, 2012

6

Comparative effectiveness: beyond the buzz

Annemans, Lieven

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 77 KB

english, 2012

7

Erratum

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 45 KB

english, 2012

8

Adherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy

Han, Steven-Huy, Jing, Wuhua, Mena, Edward, Li, Michael, Pinsky, Brett, Tang, Hong, Hebden, Tony, Juday, Timothy

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 169 KB

english, 2012

9

Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis

Pelletier, Elise M., Pawaskar, Manjiri, Smith, Paula J., Best, Jennie H., Chapman, Richard H.

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 197 KB

english, 2012

10

Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France

Laas, Enora, Vataire, Anne-Lise, Aballea, Samuel, Valentine, William, Gligorov, Joseph, Chereau, Elisabeth, Rouzier, Roman

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 286 KB

english, 2012

11

Direct medical costs associated with atopic diseases among young children in Thailand

Ngamphaiboon, Jarungchit, Kongnakorn, Thitima, Detzel, Patrick, Sirisomboonwong, Krittawan, Wasiak, Radek

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 360 KB

english, 2012

12

One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel

Burton, Tanya M., Lacey, Michael, Liu, Fang, Yu, Yanni, Monsalvo, Maria Laura, Lang, Kathy, Sander, Stephen

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 256 KB

english, 2012

13

A cost-utility study of the use of pregabalin added to usual care in refractory neuropathic pain patients in a Swedish setting

Prettyjohns, Matthew, Sandelin, Rebecka, Lister, Steven, Norrefalk, Jan-Rickard

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 521 KB

english, 2012

14

Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia

Su, John, Prescott, Susan, Sinn, John, Tang, Mimi, Smith, Peter, Heine, Ralf G., Spieldenner, Jörg, Iskedjian, Michael

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 1.85 MB

english, 2012

15

Comparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model

Schuetz, C. Andy, van Herick, Andrew, Alperin, Peter, Peskin, Barbara, Hsia, Judith, Gandhi, Sanjay

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 499 KB

english, 2012

16

Treatment of candidemia with echinocandins: data on hospital resource use from a real world setting

Wade, Rolin L., Chaudhari, Paresh, Campbell, Rebecca S., Hays, Harlen D., Nathanson, Brian H., Yi, Jing, Horn, David

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 320 KB

english, 2012

17

Changes in COPD demographics and costs over 20 years

Blanchette, Christopher M., Dalal, Anand A., Mapel, Douglas

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 190 KB

english, 2012

18

Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents

Gao, Xin, Wendling, Daniel, Botteman, Marc F., Carter, John A., Rao, Sumati, Cifaldi, Mary

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 152 KB

english, 2012

19

Patient and parent preferences for immunoglobulin treatments: a conjoint analysis

Mohamed, Ateesha F., Kilambi, Vikram, Luo, Michelle P., Iyer, Ravi G., Li-McLeod, Josephine M.

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 423 KB

english, 2012

20

Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma

Wong, Michael K., Mohamed, Ateesha F., Hauber, A. Brett, Yang, Jui-Chen, Liu, Zhimei, Rogerio, Jaqueline, Garay, Carlos A.

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 598 KB

english, 2012

21

Letter to the editor

Granda, Ángel Sanz, Jurado, Laura García, Sánchez, Carlos Polanco

Journal:

Journal of Medical Economics

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012